Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Capital Expenditures (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Capital Expenditures for 6 consecutive years, with -$390000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 101.42% to -$390000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $128000.0 through Dec 2025, down 99.75% year-over-year, with the annual reading at $128000.0 for FY2025, 99.59% down from the prior year.
  • Capital Expenditures for Q4 2025 was -$390000.0 at Strata Critical Medical, down from $284000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $27.4 million in Q4 2024, with the low at -$2.4 million in Q2 2025.
  • Average Capital Expenditures over 5 years is $3.2 million, with a median of $437000.0 recorded in 2022.
  • The sharpest move saw Capital Expenditures surged 6700.0% in 2021, then tumbled 114.76% in 2025.
  • Over 5 years, Capital Expenditures stood at $264000.0 in 2021, then crashed by 95.83% to $11000.0 in 2022, then crashed by 12736.36% to -$1.4 million in 2023, then soared by 2070.0% to $27.4 million in 2024, then tumbled by 101.42% to -$390000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$390000.0, $284000.0, and -$2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.